Adjuvant therapy for resectable colorectal carcinoma with 5-fluorouracil portal vein infusion

J Chemother. 1997 Apr;9(2):140-1. doi: 10.1179/joc.1997.9.2.140.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage*
  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / therapeutic use
  • Carcinoma / drug therapy*
  • Carcinoma / radiotherapy
  • Carcinoma / surgery
  • Chemotherapy, Adjuvant
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / radiotherapy
  • Colorectal Neoplasms / surgery
  • Fluorouracil / administration & dosage*
  • Fluorouracil / adverse effects
  • Fluorouracil / therapeutic use
  • Humans
  • Infusions, Intravenous
  • Portal Vein
  • Postoperative Period
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Fluorouracil